About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AUPH - Aurinia Pharmaceutic...| Previous Close | $13.63 | Open | $13.91 |
| Volume | 5.01M | Market Cap | 1.683B |
| Yield | Last Dividend |
| Victoria???s Aurinia Pharmaceuticals day... | 01/17/21 |
| Until recently there was no FDA-approved drug to treat Lupus, a chronic disease that prompts the immune system to attack the body???s organs | |
| STAT+: Aurinia in ???show-me phase??? as... | 01/15/21 |
| Aurinia Pharmaceuticals is in a "show-me phase" as the FDA nears an approval decision on its drug for lupus nephritis, a serious autoimmune kidney dis... | |
| Aurinia Pharmaceuticals to Present at Tw... | 01/08/21 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the ???Company???) today announced that members o... | |
| My Top Six 2020 Stock Picks Gained an Av... | 12/30/20 |
| A few of these names continue to look good in 2021???.AUPH | |
| H.C. Wainwright Stick to Their Buy Ratin... | 12/16/20 |
| H.C. Wainwright Stick to Their Buy Rating for Aurinia Pharmaceuticals | |
| Aurinia and Lonza Announce Exclusive Agr... | 12/15/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (???Aurinia???) and Lonza Ltd. (SIX: LONN) ("Lonza... | |
| Aurinia Pharmaceuticals to Present at th... | 12/02/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the ???Company???) today announced its participat... | |
| Aurinia Pharmaceuticals to Present at th... | 11/12/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the ???Company???) today announced that members o... | |
| Why Aurinia Pharmaceuticals Stock Is Tra... | 11/03/20 |
| Share this Stock Information Aurinia Pharmaceuticals (NASDAQ: AUPH) shares are trading lower on Tuesday after the company reported its AUDREY trial in... | |
| Aurinia Pharma???s Dry Eye Study Blanks ... | 11/03/20 |
| No summary available. | |
| The Daily Biotech Pulse: Aurinia Pulls T... | 11/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 2) Bio-... | |
| Aurinia Tanks 10% As Dry Eye Trial Fails... | 11/03/20 |
| Shares in Aurinia Pharmaceuticals (AUPH) tanked 10% after-hours after the biopharma announced disappointing topline data from the Phase 2/3 Audrey cli... | |
| Aurinia Announces Outcome of AUDREY??? C... | 11/02/20 |
| Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage clinical biopharmaceutical company, today ann... | |
| Aurinia Announces European Investigator-... | 10/27/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage c... | |
| Aurinia Presents Voclosporin Efficacy an... | 10/22/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage c... | |
| Analysts Anticipate Aurinia Pharmaceutic... | 10/20/20 |
| Equities research analysts expect that Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) will post earnings per share of ($0.22) for the current qua... | |
| Shark Bites: Positioning for a Positive ... | 10/05/20 |
| AUPH has two very large market opportunities for its voclosporin drug???.AUPH | |
| Aurinia Completes Final Patient Treatmen... | 09/28/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (Aurinia or the Company), a late-stage clinical bio... | |
| Aurinia Announces New Employment Inducem... | 09/04/20 |
| VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (???Aurinia??? or the ???Company???... | |
| Recap: Aurinia Pharmaceuticals Q2 Earnin... | 08/11/20 |
| Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) were unchanged after-market trading after the company reported Q2 results. Quarterly Results Earnings ... | |
| Aurinia Pharmaceuticals : to Present at ... | 08/04/20 |
| Aurinia Pharmaceuticals Inc. today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside ch... | |
| Aurinia Pharmaceuticals to Report Second... | 07/30/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the ???Company???) today announced that it will r... | |
| Aurinia Pharmaceuticals Inc. Completes U... | 07/28/20 |
| On July 27, 2020, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (Aurinia or the Company) closed its underwritten public offering of 13,333,334 ... | |
| Aurinia secures $200M capital raise (NAS... | 07/27/20 |
| Aurinia Pharmaceuticals (AUPH -2.3%) has closed its public offering of ~13.3M common shares at $15 per share. Gross proceeds were ~$200M. | |
| Celsion among healthcare gainers; Aurini... | 07/23/20 |
| Gainers: Milestone Pharmaceuticals MIST +137%. CymaBay Therapeutics CBAY +34%. Entera Bio ENTX +31%. Celsion (NASDAQ:CLSN) +27%. AMAG Pharmaceuticals ... | |
| Aurinia Announces Public Offering of Com... | 07/22/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage c... | |
| Aurinia Pharma Surges 9% On Priority Rev... | 07/22/20 |
| Shares in Aurinia Pharma (AUPH) surged 9% in Tuesday???s extended trading after the U.S. The post Aurinia Pharma Surges 9% On Priority Review For Lupu... | |
| Aurinia Completes Patient Enrollment Int... | 06/22/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage ... | |
| CVCA Announces 2020 Deal of The Year, 20... | 06/12/20 |
| TORONTO , June 12, 2020 /PRNewswire/ - The Canadian Venture Capital and Private Equity Association (CVCA) today announced the winners of the 2020 CVCA... | |
| Aurinia Presents Additional AURORA Pivot... | 06/09/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage c... | |
| Buy rating | 11/03/20 |
| HC Wainwright & Co. maintains Buy rating and lowers Price Target from $34.00 to $28.00 | |
| Date | 2020-11-10 (AMC) | Est. (EPS/Rev.) | ($0.15)/ 50K |
| Actual (EPS/Rev.) | $-0.28/ $29.00 K | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| The Winning Trader | Stock Trader D | 60.00 % | Subscribe |
| Symmetry Options | Symmetry Options | 33.00 % | Follow |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
| cerevisiology | John Cho | 19.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
